Feder K - Search Results

1

A noncanonical enzymatic function of PIWIL4 maintains genomic integrity and leukemic growth in AML.

Bamezai S, Pulikkottil AJ, Yadav T, Vegi NM, Mueller J, Mark J, Mandal T, Feder K, Ihme S, Song C, Rosler R, Wiese S, Hoell JI, Kloetgen A, Karsan A, Kumari A, Wojenski L, Sinha AU, Gonzalez-Menendez I, Quintanilla-Martinez L, Donato E, Trumpp A, Kruse E, Hamperl S, Zou L, Rawat VPS, Buske C. Bamezai S, et al. Among authors: feder k. Blood. 2023 Jul 6;142(1):90-105. doi: 10.1182/blood.2022018651. Blood. 2023. PMID: 37146239 Free article.

2

TET3 promotes AML growth and epigenetically regulates glucose metabolism and leukemic stem cell associated pathways.

Pulikkottil AJ, Bamezai S, Ammer T, Mohr F, Feder K, Vegi NM, Mandal T, Kohlhofer U, Quintanilla-Martinez L, Sinha A, Buske C, Rawat VPS. Pulikkottil AJ, et al. Among authors: feder k. Leukemia. 2022 Feb;36(2):416-425. doi: 10.1038/s41375-021-01390-3. Epub 2021 Aug 30. Leukemia. 2022. PMID: 34462525

3

MEIS2 Is an Oncogenic Partner in AML1-ETO-Positive AML.

Vegi NM, Klappacher J, Oswald F, Mulaw MA, Mandoli A, Thiel VN, Bamezai S, Feder K, Martens JHA, Rawat VPS, Mandal T, Quintanilla-Martinez L, Spiekermann K, Hiddemann W, Döhner K, Döhner H, Stunnenberg HG, Feuring-Buske M, Buske C. Vegi NM, et al. Among authors: feder k. Cell Rep. 2016 Jul 12;16(2):498-507. doi: 10.1016/j.celrep.2016.05.094. Epub 2016 Jun 23. Cell Rep. 2016. PMID: 27346355 Free article.

4

Differences in expression and function of LEF1 isoforms in normal versus leukemic hematopoiesis.

Feder K, Edmaier-Schröger K, Rawat VPS, Kirsten N, Metzeler K, Kraus JM, Döhner K, Döhner H, Kestler HA, Feuring-Buske M, Buske C. Feder K, et al. Leukemia. 2020 Apr;34(4):1027-1037. doi: 10.1038/s41375-019-0635-1. Epub 2019 Nov 22. Leukemia. 2020. PMID: 31758089

5

Polygenic Risk for Substance Use Disorders as Predictors of Substance Use Initiation Among African American Youth.

Sosnowski DW, Rabinowitz JA, Feder KA, Strickland JC, Hancock DB, Uhl GR, Ialongo NS, Maher BS. Sosnowski DW, et al. Among authors: feder ka. J Stud Alcohol Drugs. 2024 Nov 21. doi: 10.15288/jsad.24-00397. Online ahead of print. J Stud Alcohol Drugs. 2024. PMID: 39569729

6

Client and program-level factors associated with planned use of medications for opioid use disorder in specialty substance use treatment programs: Evidence from linked administrative data and survey data.

Feder KA, Li Y, Burke KN, Byrne L, Desai IK, Saloner B, Krawczyk N. Feder KA, et al. J Subst Use Addict Treat. 2024 Oct 21;168:209545. doi: 10.1016/j.josat.2024.209545. Online ahead of print. J Subst Use Addict Treat. 2024. PMID: 39442630

7

Association of primary care engagement with initiation and continuation of medication treatment for opioid use disorder among persons with a history of injection drug use.

Sosnowski DW, Feder KA, Genberg BL, Mehta SH, Kirk GD. Sosnowski DW, et al. Among authors: feder ka. Drug Alcohol Depend. 2024 Sep 1;262:111383. doi: 10.1016/j.drugalcdep.2024.111383. Epub 2024 Jul 5. Drug Alcohol Depend. 2024. PMID: 38986240

8

Trainees' perspectives on sickle cell education: a qualitative needs assessment.

Prince EJ, Feder KJ, Calhoun C, Lee AI, Carroll CP, Restrepo V, Van Doren L. Prince EJ, et al. Among authors: feder kj. BMC Med Educ. 2024 Jul 2;24(1):715. doi: 10.1186/s12909-024-05696-5. BMC Med Educ. 2024. PMID: 38956512 Free PMC article.

9

Barriers and facilitators to use of buprenorphine in state-licensed specialty substance use treatment programs: A survey of program leadership.

Burke KN, Krawczyk N, Li Y, Byrne L, Desai IK, Bandara S, Feder KA. Burke KN, et al. Among authors: feder ka. J Subst Use Addict Treat. 2024 Jul;162:209351. doi: 10.1016/j.josat.2024.209351. Epub 2024 Mar 17. J Subst Use Addict Treat. 2024. PMID: 38499248

10

Time-to-completion of COVID-19 vaccination primary series varies by HIV viral load status among people who inject drugs in Baltimore, Maryland.

Baker P, Cepeda JA, Schluth C, Astemborski J, Feder KA, Rudolph J, Sun J, Kirk GD, Mehta SH, Genberg BL. Baker P, et al. Among authors: feder ka. Prev Med Rep. 2023 Sep 28;36:102448. doi: 10.1016/j.pmedr.2023.102448. eCollection 2023 Dec. Prev Med Rep. 2023. PMID: 37840593 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters